Optimus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OPTIMUS, and what generic and branded alternatives to OPTIMUS drugs are available?
OPTIMUS has two approved drugs.
There are two tentative approvals on OPTIMUS drugs.
Summary for Optimus
US Patents: | 0 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for Optimus: | See patent lawsuits for Optimus |
Drugs and US Patents for Optimus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Optimus | BREXPIPRAZOLE | brexpiprazole | TABLET;ORAL | 213758-006 | Oct 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Optimus | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 213944-001 | Sep 14, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Optimus | BREXPIPRAZOLE | brexpiprazole | TABLET;ORAL | 213758-004 | Oct 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Optimus | BREXPIPRAZOLE | brexpiprazole | TABLET;ORAL | 213758-005 | Oct 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Optimus | BREXPIPRAZOLE | brexpiprazole | TABLET;ORAL | 213758-001 | Oct 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.